| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/16/2009 | WO2009048932A2 Methods to regulate mirna processing by targeting lin-28 |
| 04/16/2009 | WO2009048839A2 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 04/16/2009 | WO2009048769A2 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 04/16/2009 | WO2009048631A1 PREPARATION OF PURIFIED COVALENTYLY CROSS-LINKED A β OLIGOMERS AND USES THEREOF |
| 04/16/2009 | WO2009048607A1 Vaccine delivery via microneedle arrays |
| 04/16/2009 | WO2009048354A1 Method for overproducing anti-her2/neu oncogene antibodies in plant |
| 04/16/2009 | WO2009048072A1 ANTIBODY TARGETING OSTEOCLAST-RELATED PROTEIN Siglec-15 |
| 04/16/2009 | WO2009047610A1 Immune stimulatory oligonucleotide analogs containing modified sugar moieties |
| 04/16/2009 | WO2009047571A1 Botulinum neurotoxin vaccine |
| 04/16/2009 | WO2009047363A1 Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosis |
| 04/16/2009 | WO2009047360A1 Il-21 antibodies |
| 04/16/2009 | WO2009047331A1 Medicaments and methods for treating mesothelioma |
| 04/16/2009 | WO2009047009A1 Fusion polypeptide comprising s-antigen repeat units |
| 04/16/2009 | WO2009046984A1 Hiv preventive vaccine based on hiv specific antibodies |
| 04/16/2009 | WO2009046975A1 COMPOSITION FOR TREATING PROSTATE CANCER (PCa) |
| 04/16/2009 | WO2009046974A2 Composition for treating lung cancer, particularly of non-small lung cancers (nsclc) |
| 04/16/2009 | WO2009046739A1 Composition for treating prostate cancer (pca) |
| 04/16/2009 | WO2009046738A1 Composition for treating lung cancer, particularly of non-small lung cancers (nsclc) |
| 04/16/2009 | WO2009046541A1 MODULATION OF SIRPα - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR |
| 04/16/2009 | WO2009046498A1 A method of transfection and compositions therefor |
| 04/16/2009 | WO2009046497A1 Method of eliciting an immune response against pandemic influenza virus |
| 04/16/2009 | WO2009025770A9 A heterologous prime-boost immunization regimen |
| 04/16/2009 | WO2009021022A3 Modulating the activity of nuclear receptors in order to treat hypoxia-related disorders |
| 04/16/2009 | WO2009020236A3 Baculoviral vectors with a dual vertebrate and baculovirus promoter controlling an immunogenic fusion gene |
| 04/16/2009 | WO2009015279A3 Agents and methods for inhibition of airway hyperresponsiveness |
| 04/16/2009 | WO2008157530A3 Vaccine design methodology |
| 04/16/2009 | WO2008140610A9 Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast |
| 04/16/2009 | WO2008136848A4 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 04/16/2009 | WO2008079372A3 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008058752A3 Lentiviral vectors for gene transfer in quiescent (g0) cells |
| 04/16/2009 | WO2008055916A9 New antigens for paratuberculosis diagnosis and vaccination |
| 04/16/2009 | WO2008036449A3 Chemical antibodies for immunotherapy and imaging |
| 04/16/2009 | WO2008008052A3 Improved ultrasonic inspection using acoustic modeling |
| 04/16/2009 | WO2007120656A3 Uses and compositions for treatment of rheumatoid arthritis |
| 04/16/2009 | WO2007113819A3 Methods and compositions for preventing and treating streptococcus pneumoniae infection |
| 04/16/2009 | WO2007111628A3 Mxa as an antiviral drug and as a target for identification of antiviral drugs for dna virus infections |
| 04/16/2009 | WO2007102797A3 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 04/16/2009 | WO2007098201A3 Shiga toxoid chimeric proteins |
| 04/16/2009 | WO2007063424A3 The modulation of immunity and ceacam1 activity |
| 04/16/2009 | WO2007030451A3 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 04/16/2009 | WO2007027748A3 C/clp antagonists and methods of use thereof |
| 04/16/2009 | WO2007018853A3 Secretion of antibodies without signal peptides from bacteria |
| 04/16/2009 | WO2007011702A3 Use of egfr inhibitors to prevent or treat obesity |
| 04/16/2009 | WO2007008848A3 Monomethylvaline compounds having phenylalanine carboxy modifications at the c-terminus |
| 04/16/2009 | WO2007005715A3 Staphylococcal antibodies which cross-react with fungal antigens |
| 04/16/2009 | WO2007005559A3 Tat-005 and methods of assessing and treating cancer |
| 04/16/2009 | WO2007002362A3 A direct drug delivery system based on thermally responsive biopolymers |
| 04/16/2009 | WO2007002087A3 Cdc6s as modifiers of the pten/akt pathway and methods of use |
| 04/16/2009 | WO2007001332A3 Anti-pathogen immunoadhesins |
| 04/16/2009 | WO2006138449A3 Method for identifying a mhc class ii-dependent tumor-associated t helper cell antigen |
| 04/16/2009 | WO2006135428A3 Methods and compositions for inducing an immune response against multiple antigens |
| 04/16/2009 | WO2006130773A3 Methods of treating brain tumors with antibodies |
| 04/16/2009 | WO2006130399A3 Therapeutic combinations and methods including irm compounds |
| 04/16/2009 | WO2006125229A3 Use of tnf inhibitor for treatment of erosive polyarthritis |
| 04/16/2009 | WO2006122187A3 Treating and evaluating inflammatory disorders |
| 04/16/2009 | WO2006119291A3 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 04/16/2009 | WO2006113665A3 Covalent diabodies and uses thereof |
| 04/16/2009 | WO2006113528A3 Expressing hepatitis b virus surface antigen for vaccine preparation |
| 04/16/2009 | WO2006112925A3 Cxcr3 is a gliadin receptor |
| 04/16/2009 | WO2006110214A3 Antibodies against mammalian metapneumovirus |
| 04/16/2009 | WO2006105488A3 Antibodies and related molecules that bind to 161p2f10b proteins |
| 04/16/2009 | WO2006103639A3 Methods and reagents for identifying/isolating t regulatory (treg) cells and for treating individuals |
| 04/16/2009 | WO2006089095A3 Treating neurological disorders |
| 04/16/2009 | WO2006086345A3 Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity |
| 04/16/2009 | WO2006083562A3 Method and multicomponent conjugates for treating cancer |
| 04/16/2009 | WO2006081462A3 Multi-component inhibitors of nucleic acid polymerases |
| 04/16/2009 | WO2006078272A3 Rhabdoviral n-fusion proteins as carrier for foreign antigens |
| 04/16/2009 | WO2006074179A3 Blockade of elr+cxc chemokines as a treatment for inflammatory and autoimmune disease |
| 04/16/2009 | WO2006060021A3 Bifunctional fusion proteins containing the flt3 ligand |
| 04/16/2009 | WO2006058043A3 Contraceptive vaccines for dogs and cats based on egg membrane antigens |
| 04/16/2009 | WO2006055008A3 Implantable sensors and implantable pumps and anti-scarring agents |
| 04/16/2009 | WO2006047633A3 Radial glial cells promote nerve regeneration and functional recovery following spinal cord injury |
| 04/16/2009 | WO2006044923A3 Yeast-based therapeutic for chronic hepatitis c infection |
| 04/16/2009 | WO2006036882A3 Methods for determining and lowering caffeine concentration in fluids |
| 04/16/2009 | WO2006031291A3 A novel class of therapeutic protein based molecules |
| 04/16/2009 | WO2006023332A3 Method for the inhibition of angiogenesis or cancer using protective antigen related molecules |
| 04/16/2009 | WO2006012359A3 Methods for inducing the differentiation of blood monocytes into functional dendritic cells |
| 04/16/2009 | WO2005115477A3 Non-natural ribonuclease conjugates as cytotoxic agents |
| 04/16/2009 | WO2005112567A3 Vaginal microbicide |
| 04/16/2009 | WO2005094279A3 Immortalized human tuberous sclerosis null angiomyolipoma cell and method of use thereof |
| 04/16/2009 | WO2005069994A3 Folate conjugates and complexes |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | WO2005035714A3 Vaccines for cancer, autoimmune disease and infections |
| 04/16/2009 | WO2004091524A3 Respiratory virus vaccines |
| 04/16/2009 | WO2004074433A3 Rag polypeptides, nucleic acids, and their use |
| 04/16/2009 | US20090099341 Heparanase specific molecular probes and their use in research and medical applications |
| 04/16/2009 | US20090099336 using the conjugates in the inhibition of cell growth; cancer; monoclonal antibody or epitope-binding fragment thereof, that recognizes and binds the CA6 glycotope |
| 04/16/2009 | US20090099090 Of given sequence; human leukocyte antigen; induce cytotoxic T cells; use of them as cancer vaccines, and methods for treatment and prevention of cancers based on them |
| 04/16/2009 | US20090099073 Albumin Fusion Proteins |
| 04/16/2009 | US20090098654 Selectable genetic marker for use in pasteurellaceae species |
| 04/16/2009 | US20090098632 Compositions comprising viruses and methods for concentrating virus preparations |
| 04/16/2009 | US20090098629 Comprises urogenital system specific protein for diagnosing and treating tumors; antiproliferative agents; genetic vaccine; 22P4F11 transcript and/or protein represent a useful diagnostic marker and/or therapeutic target for prostate cancer |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098197 Cancer vaccine comprising a cancer antigen based on the product of a tumor suppressor gene wt1 and a cationic liposome |
| 04/16/2009 | US20090098167 PHL P 1 Allergen Derivative |
| 04/16/2009 | US20090098166 Chimeric MSP-based malaria vaccine |
| 04/16/2009 | US20090098165 Methods and compositions for immunization against chlamydial infection and disease |
| 04/16/2009 | US20090098164 Spore associated display |
| 04/16/2009 | US20090098163 Mutant F. turlarensis strain and uses thereof |